Compare companies
Shalby Limited | Sun Pharmaceutical Industries Limited | Divi's Laboratories Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 205.98 | 1683.45 | 5614 | |||
Price priv. | ||||||
Number of shares, million | 108.21 | 2399.33 | 265.47 | |||
Capitalization, billion | 18.14 | 2720 | 970.26 | |||
EBITDA, billion | 1.98 | 138.36 | 25.43 | |||
EV, billion | 29.8 | 3800.17 | 907.35 | |||
Profit and loss report | ||||||
Net profit, billion | 0.8408 | 95.76 | 16 | |||
Revenue, billion | 9.34 | 477.58 | 78.45 | |||
EPS | 7.77 | 39.91 | 60.27 | |||
Balance | ||||||
Assets, billion | 16.08 | 854.63 | 154.7 | |||
Debt, billion | 3.78 | 32.74 | 0.03 | |||
Balance cost, billion | 10 | 636.67 | 135.71 | |||
Cash, billion | 0.2718 | 92.86 | 3.63 | |||
Coefficients | ||||||
Dividend yield, % | 0.4272 | 0.7986 | 1.22 | |||
Dividend | 1.2 | 15.5 | 30 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 15.42 | 30.26 | 49.75 | |||
P/S | 2.82 | 8.08 | 11.61 | |||
P/BV | 2.61 | 5.75 | 6.71 | |||
P/E | 31.27 | 40.31 | 56.93 | |||
Ev/Ebitda | 15.04 | 27.47 | 35.68 | |||
Debt/Ebitda | 1.91 | 0.2366 | 0.0012 | |||
Efficiency | ||||||
ROE | 8.72 | 16.01 | 12.15 | |||
ROA | 5.82 | 11.52 | 10.7 | |||
ROIC | 7.28 | 18.08 | 20.52 | |||
Ebitda margin | 21.21 | 28.97 | 32.42 | |||
Net margin | 9 | 20.05 | 20.4 | |||
Momentum | ||||||
1 week, price changes | -0.8663 % | +4.61 % | +0.6319 % | |||
1 month, price changes | -0.0388 % | -0.614 % | -5.96 % | |||
3 months, price changes | -14.67 % | -7.17 % | -4.47 % | |||
6 months, price changes | -28.17 % | -9.64 % | +2.46 % | |||
1 year, price changes | -11.23 % | +8.74 % | +61.07 % | |||
3 years, price changes | +58.08 % | +89.32 % | +27.53 % | |||
5 years, price changes | +105.57 % | +306.04 % | +164.59 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription